Avoro-Capital-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "ASND",
  "CNTA",
  "ALKS",
  "KRYS",
  "ARGX",
  "MDGL",
  "APLS",
  "ARWR",
  "FOLD",
  "TSHA",
  "TRML",
  "KYMR",
  "GLUE",
  "AUTL",
  "MNKD",
  "SEPN",
  "WHWK",
  "UTHR",
  "RNA",
  "MLTX",
  "SLNO",
  "QURE",
  "ETNB",
  "SRPT",
  "XENE",
  "VERA",
  null,
  "RARE",
  "PCVX",
  "BCRX",
  "BPMC"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 33
Total Value: 6406567714
Accession Number: 0001104659-25-048904
Form Type: 13F-HR
CIK: avoro-capital-advisors
Manager Name: Avoro-Capital-Advisors

Data Enrichment

97% identified

32 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

33 positions • $6.4B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:8.1M

Value:$59.1M

% of Portfolio:0.9% ($59.1M/$6.4B)

Centessa Pharmaceuticals plc

CNTA|152309100

Shares:4.0M

Value:$58.2M

% of Portfolio:0.9% ($58.2M/$6.4B)

89bio, Inc.

ETNB|282559103

Shares:6.3M

Value:$46.2M

% of Portfolio:0.7% ($46.2M/$6.4B)

MANNKIND CORP

MNKD|56400P706

Shares:8.8M

Value:$44.0M

% of Portfolio:0.7% ($44.0M/$6.4B)

Vaxcyte, Inc.

PCVX|92243G108

Shares:1.0M

Value:$37.8M

% of Portfolio:0.6% ($37.8M/$6.4B)

Tourmaline Bio, Inc.

TRML|89157D105

Shares:2.4M

Value:$36.9M

% of Portfolio:0.6% ($36.9M/$6.4B)

Ultragenyx Pharmaceutical Inc.

RARE|90400D108

Shares:830.0K

Value:$30.1M

% of Portfolio:0.5% ($30.1M/$6.4B)

Taysha Gene Therapies, Inc.

TSHA|877619106

Shares:20.0M

Value:$27.8M

% of Portfolio:0.4% ($27.8M/$6.4B)

uniQure N.V.

QURE|N90064101

Shares:2.2M

Value:$23.1M

% of Portfolio:0.4% ($23.1M/$6.4B)

Monte Rosa Therapeutics, Inc.

GLUE|61225M102

Shares:4.6M

Value:$21.6M

% of Portfolio:0.3% ($21.6M/$6.4B)

Autolus Therapeutics plc

AUTL|05280R100

Shares:9.9M

Value:$15.4M

% of Portfolio:0.2% ($15.4M/$6.4B)

Septerna, Inc.

SEPN|81734D104

Shares:1.3M

Value:$7.7M

% of Portfolio:0.1% ($7.7M/$6.4B)

Whitehawk Therapeutics, Inc.

WHWK|00032Q104

Shares:2.8M

Value:$5.1M

% of Portfolio:0.1% ($5.1M/$6.4B)

Instrument	Shares		Other Manager	Value	% of Portfolio
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	8.1M	QoQ 0.00% (-0) YoY +12.74% (-911.1K)	All Managers (Combined)	$59.1M	0.9% ($59.1M/$6.4B)	QoQ -14.16% (-$9.8M) YoY -9.18% (-$6.0M)
Centessa Pharmaceuticals plc(CNTAcusip152309100)	4.0M	QoQ NEW(+4.0M) YoY NEW(+4.0M)	All Managers (Combined)	$58.2M	0.9% ($58.2M/$6.4B)	QoQ NEW(+$58.2M) YoY NEW(+$58.2M)
89bio, Inc.(ETNBcusip282559103)	6.3M	QoQ +54.87% (+2.3M) YoY NEW(+6.3M)	All Managers (Combined)	$46.2M	0.7% ($46.2M/$6.4B)	QoQ +43.98% (+$14.1M) YoY NEW(+$46.2M)
MANNKIND CORP(MNKDcusip56400P706)	8.8M	QoQ 0.00% (-0) YoY -2.77% (-250.0K)	All Managers (Combined)	$44.0M	0.7% ($44.0M/$6.4B)	QoQ -21.77% (-$12.3M) YoY +7.95% (-$3.2M)
Vaxcyte, Inc.(PCVXcusip92243G108)	1.0M	QoQ -14.89% (-175.0K) YoY +73.91% (-425.0K)	All Managers (Combined)	$37.8M	0.6% ($37.8M/$6.4B)	QoQ -60.74% (-$58.4M) YoY -3.86% (-$1.5M)
Tourmaline Bio, Inc.(TRMLcusip89157D105)	2.4M	QoQ +9.12% (-202.8K) YoY +9.12% (-202.8K)	All Managers (Combined)	$36.9M	0.6% ($36.9M/$6.4B)	QoQ -18.15% (-$8.2M) YoY -27.52% (-$14.0M)
Ultragenyx Pharmaceutical Inc.(RAREcusip90400D108)	830.0K	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$30.1M	0.5% ($30.1M/$6.4B)	QoQ -13.92% (-$4.9M) YoY -22.44% (-$8.7M)
Taysha Gene Therapies, Inc.(TSHAcusip877619106)	20.0M	QoQ 0.00% (-0) YoY +7.23% (-1.3M)	All Managers (Combined)	$27.8M	0.4% ($27.8M/$6.4B)	QoQ -19.65% (-$6.8M) YoY -48.06% (-$25.7M)
uniQure N.V.(QUREcusipN90064101)	2.2M	QoQ 0.00% (-0) YoY NEW(+2.2M)	All Managers (Combined)	$23.1M	0.4% ($23.1M/$6.4B)	QoQ -39.97% (-$15.4M) YoY NEW(+$23.1M)
Monte Rosa Therapeutics, Inc.(GLUEcusip61225M102)	4.6M	QoQ +6.91% (-300.5K) YoY +2.43% (-110.5K)	All Managers (Combined)	$21.6M	0.3% ($21.6M/$6.4B)	QoQ -28.51% (-$8.6M) YoY -32.58% (-$10.4M)
Autolus Therapeutics plc(AUTLcusip05280R100)	9.9M	QoQ 0.00% (-0) YoY -19.72% (-2.4M)	All Managers (Combined)	$15.4M	0.2% ($15.4M/$6.4B)	QoQ -34.04% (-$7.9M) YoY -80.49% (-$63.4M)
Septerna, Inc.(SEPNcusip81734D104)	1.3M	QoQ +20.49% (-227.5K) YoY NEW(+1.3M)	All Managers (Combined)	$7.7M	0.1% ($7.7M/$6.4B)	QoQ -69.53% (-$17.7M) YoY NEW(+$7.7M)
Whitehawk Therapeutics, Inc.(WHWKcusip00032Q104)	2.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$5.1M	0.1% ($5.1M/$6.4B)	QoQ -43.58% (-$3.9M) YoY -23.93% (-$1.6M)